Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway. [electronic resource]
Producer: 20181211Description: 407 p. digitalISSN:- 1471-2407
- Apoptosis -- drug effects
- Bexarotene -- chemistry
- Biomarkers
- Carcinoma, Non-Small-Cell Lung -- genetics
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Gene Expression
- Humans
- Lung Neoplasms -- genetics
- Organic Anion Transporters, Sodium-Dependent -- genetics
- PPAR gamma -- metabolism
- PTEN Phosphohydrolase -- metabolism
- Signal Transduction -- drug effects
- Symporters -- genetics
- TOR Serine-Threonine Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.